We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · April 17, 2021

Early Prednisolone for Relapse Prevention Alleviates Depression, Fatigue in AQP4-Positive NMOSD

Frontiers in Neurology


Additional Info

Disclosure statements are available on the authors' profiles:

Frontiers in Neurology
Early Treatment Initiation With Oral Prednisolone for Relapse Prevention Alleviates Depression and Fatigue in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
Front Neurol 2021 Mar 01;[EPub Ahead of Print], T Akaishi, T Takahashi, K Fujihara, T Misu, J Fujimori, Y Takai, S Nishiyama, M Abe, T Ishii, M Aoki, I Nakashima

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading